Five Pharmaceuticals

FIVE’s mission is to be the first to market publicly traded Canadian pharmaceutical Psilocybin Company specializing in R&D and Clinical Trials to help patients with PTSD, depression, drug addictions and mental health disorders in first responders and Veterans through Health Canada licensing with Good Manufacturing Practices (GMP) and ISO 9001 standards.

View in the Microdose DirectoryVisit Website